HIV-1 RNase H: Recent Progress in an Exciting, yet Little Explored, Drug Target

Author(s): Enzo Tramontano

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 6 , Issue 6 , 2006

Become EABM
Become Reviewer
Call for Editor


HIV-1 reverse transcriptase-associated ribonuclease H (RNase H) is an attractive non traditional target for drug development which has been, so far, little explored. All drugs shown to inhibit HIV-1 RNase H are reported, including the recently described classes of compounds that interact with the metal ions in the active site.

Keywords: HIV-1, Reverse transcriptase, Ribonuclease H, Inhibition, Drug development, N-hydroxyimides, Diketo acids

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2006
Page: [727 - 737]
Pages: 11
DOI: 10.2174/138955706777435733
Price: $65

Article Metrics

PDF: 2